Cite
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.
MLA
RuiJun Chen, et al. “Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.” Hypertension (0194911X), vol. 78, no. 3, Sept. 2021, pp. 591–603. EBSCOhost, https://doi.org/10.1161/HYPERTENSIONAHA.120.16667.
APA
RuiJun Chen, Suchard, M. A., Krumholz, H. M., Schuemie, M. J., Shea, S., Duke, J., Pratt, N., Reich, C. G., Madigan, D., You, S. C., Ryan, P. B., Hripcsak, G., & Chen, R. (2021). Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. Hypertension (0194911X), 78(3), 591–603. https://doi.org/10.1161/HYPERTENSIONAHA.120.16667
Chicago
RuiJun Chen, Marc A. Suchard, Harlan M. Krumholz, Martijn J. Schuemie, Steven Shea, Jon Duke, Nicole Pratt, et al. 2021. “Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.” Hypertension (0194911X) 78 (3): 591–603. doi:10.1161/HYPERTENSIONAHA.120.16667.